Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: JT - Shareholder Letter
The concern as I see it is one of the large parts of the umbrella will be the development of a larger patent portfolio either through companies like Holocom and other companies acquired that are developing patents in the future. I believe this is an integral part of the PTSC of the future. Therefore, this is a major concern for the CEO.
Share
New Message
Please login to post a reply